Zynerba Pharmaceuticals, Inc. clinical trials
Acquired by Harmony Biosciences Holdings, Inc., Oct 10, 2023 · source ↗
The registry lists 2 studies whose lead sponsor is Zynerba Pharmaceuticals, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 27, 2026.
Before and after it joined Harmony Biosciences Holdings, Inc.
- First submitted before Zynerba Pharmaceuticals, Inc. became part of Harmony Biosciences Holdings, Inc.
- 2
- First submitted after Zynerba Pharmaceuticals, Inc. became part of Harmony Biosciences Holdings, Inc.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Zynerba Pharmaceuticals, Inc.2 studies
Something wrong with this grouping? Tell us on the Harmony Biosciences Holdings, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Harmony Biosciences Holdings, Inc. studies →
- Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXSActive, not recruitingNCT03802799Phase 2/3
Sponsor listed in the registry: Zynerba Pharmaceuticals, Inc. · First submitted before Zynerba Pharmaceuticals, Inc. became part of Harmony Biosciences Holdings, Inc.
- Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)CompletedNCT03614663Phase 2/3
Sponsor listed in the registry: Zynerba Pharmaceuticals, Inc. · First submitted before Zynerba Pharmaceuticals, Inc. became part of Harmony Biosciences Holdings, Inc.